{
    "title": "Yellow fever-associated viscerotropic disease in Barcelona, Spain.",
    "doc_id": "18494699",
    "writer": "Mu√±oz J",
    "year": "2008",
    "summary": "Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. ...",
    "abstract": "Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/18494699/"
}